120.79MMarket Cap-3000P/E (TTM)
2.820High2.590Low567.42KVolume2.800Open2.830Pre Close1.52MTurnover1.37%Turnover RatioLossP/E (Static)44.74MShares6.42052wk High1.98P/B111.67MFloat Cap0.94052wk Low--Dividend TTM41.36MShs Float81.480Historical High--Div YieldTTM8.13%Amplitude0.450Historical Low2.678Avg Price1Lot Size
Cardiff Oncology Stock Forum
In a significant development that has caught the attention of investors, Cardiff Oncology Inc. (NASDAQ: CRDF) saw an impressive 24% surge in their stock price yesterday, closing at $3.58. This sudden upswing comes amidst positive sentiments from leading investment banking and institutional securities firm, Piper Sandler, which has set a bullish price target of ...
🤘🏻
Cardiff Oncology (NASDAQ: $CRDF), a clinical-stage biotechnology company, has just reported its fourth quarter results. The company beat analyst consensus estimates on both earnings and revenue, marking a significant milestone in its financial performance. $Cardiff Oncology(CRDF.US)$
https://stockregion.app/p/clinical-stage-oncology-company-beats
No comment yet